文献速递糖尿病

2006至2018年美国商业保险与联邦医疗保险优势计划糖尿病参保者临床复杂性、治疗负担、医疗使用及糖尿病相关结局的演变

Evolution of Clinical Complexity, Treatment Burden, Health Care Use, and Diabetes-Related Outcomes Among Commercial and Medicare Advantage Plan Beneficiaries With Diabetes in the U.S., 2006-2018.
PubMed 文献 · Diabetes Care · 2022-01-01

研究基于全美理赔数据库,分析2006至2018年商业保险与联邦医疗保险优势计划中糖尿病成人参保者的临床复杂性、治疗负担、医疗使用及糖尿病相关结局的年度趋势。结果显示,两组人群临床复杂性和治疗负担总体增加,急诊就诊增加,而门诊就诊在商业保险组减少、在联邦医疗保险优势计划组保持稳定。

要点

  • 商业保险组≥10种活动性健康状况比例从2006年33.3%升至2018年38.9%(P=0.001)。
  • 联邦医疗保险优势计划组≥10种活动性健康状况比例从51.6%升至65.1%(P<0.001)。
  • 两组急诊就诊次数均增加,商业保险组从0.26次增至0.29次,联邦医疗保险优势计划组从0.41次增至0.66次。

核心结论

  • 糖尿病患者中,临床复杂性和治疗负担随时间增加;急诊使用增加,患者可能因低 acuity 状况使用急诊服务。

研究设计与样本

  • 使用全国性理赔数据库,识别2006年1月1日至2019年3月31日期间符合糖尿病理赔标准的商业保险和联邦医疗保险优势计划参保者,量化2006至2018年年度趋势。
  • 商业保险组纳入1,470,799例患者,联邦医疗保险优势计划组纳入1,311,903例参保者。

主要发现

  • 商业保险组≥10种活动性健康状况比例从2006年33.3%(95%CI 33.1-33.4)升至2018年38.9%(38.8-39.1)(P=0.001);使用≥3种降糖药比例从11.6%(11.5-11.7)升至23.1%(22.9-23.2)(P=0.007)。
  • 商业保险组HbA1c≥8.0%(≥64 mmol/mol)比例从2006年28.0%(27.7-28.3)升至2015年30.5%(30.2-30.7),2018年降至27.8%(27.5-28.0)(总体趋势P=0.04)。
  • 商业保险组每人每年门诊就诊次数从6.86(6.84-6.88)降至6.19(6.17-6.21)(P=0.001),急诊就诊次数从0.26(0.257-0.263)升至0.29(0.287-0.293)(P=0.001)。
  • 联邦医疗保险优势计划组≥10种活动性健康状况比例从51.6%(51.2-52.0)升至65.1%(65.0-65.2)(P<0.001);使用≥3种降糖药比例稳定在16.6%(16.3-16.9)和18.1%(18.0-18.2)(P=0.98);HbA1c≥8.0%比例从17.4%(16.7-18.1)升至18.6%(18.4-18.7)(P=0.008)。
  • 联邦医疗保险优势计划组每人每年门诊就诊次数稳定在8.01(7.96-8.06)和8.17(8.16-8.19)(P=0.23),急诊就诊次数从0.41(0.40-0.42)升至0.66(0.66-0.66)(P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize trends in clinical complexity, treatment burden, health care use, and diabetes-related outcomes among adults with diabetes. RESEARCH DESIGN AND METHODS: We used a nationwide claims database to identify enrollees in commercial and Medicare Advantage plans who met claims criteria for diabetes between 1 January 2006 and 31 March 2019 and to quantify annual trends in clinical complexity (e.g., active health conditions), treatment burden (e.g., medications), health care use (e.g., ambulatory, emergency department [ED], and hospital visits), and diabetes-related outcomes (e.g., hemoglobin A1c [HbA1c] levels) between 2006 and 2018. RESULTS: Among 1,470,799 commercially insured patients, the proportion with ≥10 active health conditions increased from 33.3% (95% CI 33.1-33.4) in 2006 to 38.9% (38.8-39.1) in 2018 (P = 0.001) and the proportion taking three or more glucose-lowering medications increased from 11.6% (11.5-11.7) to 23.1% (22.9-23.2) (P = 0.007). The proportion with HbA1c ≥8.0% (≥64 mmol/mol) increased from 28.0% (27.7-28.3) in 2006 to 30.5% (30.2-30.7) in 2015, decreasing to 27.8% (27.5-28.0) in 2018 (overall trend P = 0.04). Number of ambulatory visits per patient per year decreased from 6.86 (6.84-6.88) to 6.19 (6.17-6.21), (P = 0.001) while ED visits increased from 0.26 (0.257-0.263) to 0.29 (0.287-0.293) (P = 0.001). Among 1,311,903 Medicare Advantage enrollees, the proportion with ≥10 active conditions increased from 51.6% (51.2-52.0) to 65.1% (65.0-65.2) (P < 0.001); the proportion taking three or more glucose-lowering medications was stable at 16.6% (16.3-16.9) and 18.1% (18.0-18.2) (P = 0.98), and the proportion with HbA1c ≥8.0% increased from 17.4% (16.7-18.1) to 18.6% (18.4-18.7) (P = 0.008). Ambulatory visits per patient per year remained stable at 8.01 (7.96-8.06) and 8.17 (8.16-8.19) (P = 0.23), but ED visits increased from 0.41 (0.40-0.42) to 0.66 (0.66-0.66) (P < 0.001). CONCLUSIONS: Among patients with diabetes, clinical complexity and treatment burden have increased over time. ED utilization has also increased, and patients may be using ED services for low-acuity conditions.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Benning TJ, Heien HC, McCoy RG, et al. Evolution of Clinical Complexity, Treatment Burden, Health Care Use, and Diabetes-Related Outcomes Among Commercial and Medicare Advantage Plan Beneficiaries With Diabetes in the U.S., 2006-2018. Diabetes Care. 2022. PMID: 35926104. doi:10.2337/dc21-2623

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。